Journal of the American Pharmacists Association : JAPhA
-
J Am Pharm Assoc (2003) · Sep 2004
Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10 mg tablets.
To determine the weight variation and calculated dosing variability of tablet fragments upon splitting unscored cyclobenzaprine hydrochloride 10 mg tablets using two common tablet splitting devices. ⋯ Tablet fragments obtained after splitting this generic cyclobenzaprine 10 mg product varied considerably in weight and estimated drug content. Accordingly, splitting cyclobenzaprine 10 mg tablets to achieve 5 mg doses could result in unpredictable dosing and therapeutic response.
-
J Am Pharm Assoc (2003) · Jul 2004
Comparative StudyMedication error reporting by community pharmacists in Vermont.
To document community pharmacists' awareness and use of the United States Pharmacopeia Medication Errors Reporting (USP MER) program. ⋯ The majority of Vermont community pharmacists were aware of USP MER. However, use was low. Barriers to reporting to a common system such as USP MER may differ depending on pharmacy type. Further research to document the barriers to submitting reports is warranted.
-
To summarize a resource document that explains the concept and components of continuing professional development (CPD) for pharmacists, describes some of the drivers behind the reevaluation of current systems of continuing pharmacy education (CE), defines relevant terms, and outlines some experiences with CPD in selected countries that have already adopted the model. ⋯ Interest in and support for the concept of CPD is growing. Case studies of successful implementation in the United States and other countries now exist. Further discussion on the implications of widespread implementation for pharmacists in the United States is needed.
-
J Am Pharm Assoc (2003) · Jul 2004
Media coverage of controlled substance diversion through theft or loss.
To determine the frequency of media reports of controlled substance diversion. ⋯ A balanced approach to the prevention of controlled substance diversion, aimed at reducing illicit acquisition of drugs from theft and loss as well as from prescribing and dispensing, may produce the greatest success without adversely affecting the quality of patient care.